The Relevance of Lenvatinib in Advanced Hepatocellular Carcinoma: Insights from a Prospective Observational Cohort in South India
Drugs - Real World Outcomes · 2026-06 · 13 (2) · 253-264
DOI: 10.1007/s40801-026-00554-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs - Real World Outcomes, online erschienen am 20.04.2026. Verfasst von Joe Jose und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Regional Cancer Centre, Trivandrum, Kerala, 695011, India. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NATCO.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medical Oncology, Regional Cancer Centre, Trivandrum, Kerala, 695011, India.
- Department of Medical Oncology, Regional Cancer Centre, Trivandrum, Kerala, 695011, India. dranooptm@gmail.com.
Förderung
- NATCO
Zitieren
APA
Jose, J., Ignatious, S. V., & Anoop, T. M. (2026). The Relevance of Lenvatinib in Advanced Hepatocellular Carcinoma: Insights from a Prospective Observational Cohort in South India. Drugs - Real World Outcomes, 13(2), 253-264. https://doi.org/10.1007/s40801-026-00554-w
Vancouver
Jose J, Ignatious SV, Anoop TM. The Relevance of Lenvatinib in Advanced Hepatocellular Carcinoma: Insights from a Prospective Observational Cohort in South India. Drugs - Real World Outcomes. 2026;13(2):253-264. doi:10.1007/s40801-026-00554-w
BibTeX
@article{Jose2026,
author = {Jose, Joe and Ignatious, Shibu V and Anoop, Thattungal Manoharan},
title = {The Relevance of Lenvatinib in Advanced Hepatocellular Carcinoma: Insights from a Prospective Observational Cohort in South India},
journal = {Drugs - Real World Outcomes},
year = {2026},
volume = {13},
number = {2},
pages = {253--264},
doi = {10.1007/s40801-026-00554-w}
}
EUVIMED